Meagher R C, Salvado A J, Wright D G
Department of Hematology, Walter Reed Army Institute of Research, Washington, DC 20307-5100.
Blood. 1988 Jul;72(1):273-81.
To better understand the limited hematopoietic life span of human marrow "Dexter" cultures, we developed a miniaturized, two-stage culture system with which in vitro production of hematopoietic progenitors could be reproducibly detected and quantified. Light-density, gradient-separated human marrow cells were inoculated into Leighton slide tubes, and adherent ("stromal") cell layers were allowed to develop on the removable coverslips within these tubes during an initial 4 weeks of culture. Once stromal cell layers were established, cultures were irradiated (800 cGy) to eliminate all residual hematopoietic progenitors. The cultures were then recharged with autologous, cryopreserved marrow cells (enriched for BFU-E and CFU-GM) to reconstitute stem cell populations and to initiate in vitro hematopoiesis. Most progenitor cells added to irradiated cultures were no longer detectable by clonal assays within one to four days after recharge. Nonetheless, stable populations of adherent BFU-E and CFU-GM became established in these cultures within 24 to 48 hours, and when the total numbers of progenitors (adherent and nonadherent) were measured at weekly intervals thereafter, it was evident that both BFU-E and CFU-GM were generated in vitro. However, progenitor cell production declined as neutrophils and macrophages accumulated in the cultures. Moreover, with this accumulation of mature myeloid cells, increasing levels of O2- and H2O2 could be detected in the cultures, and it was found that the addition of oxidant scavengers (catalase and mannitol) to culture media enhanced the weekly expansions of progenitor cell numbers that could be measured. These findings support the conclusion that reactive O2 intermediates generated by mature myeloid cells have a role in limiting the duration and extent of hematopoietic progenitor cell self-renewal in long-term "Dexter" cultures of human marrow.
为了更好地理解人骨髓“德克斯特”培养物中造血寿命有限的情况,我们开发了一种小型化的两阶段培养系统,利用该系统可重复检测和定量体外造血祖细胞的产生。将低密度、经梯度分离的人骨髓细胞接种到莱顿玻片管中,在最初4周的培养过程中,让贴壁(“基质”)细胞层在这些管内可移除的盖玻片上生长。一旦建立了基质细胞层,就对培养物进行辐照(800 cGy)以消除所有残留的造血祖细胞。然后用自体冷冻保存的骨髓细胞(富含爆式红系集落形成单位和粒-巨噬细胞集落形成单位)对培养物进行再接种,以重建干细胞群体并启动体外造血。添加到辐照培养物中的大多数祖细胞在再接种后1至4天内通过克隆测定法不再可检测到。尽管如此,贴壁的爆式红系集落形成单位和粒-巨噬细胞集落形成单位在这些培养物中于24至48小时内建立起稳定群体,此后每周测量祖细胞(贴壁和非贴壁)总数时,很明显爆式红系集落形成单位和粒-巨噬细胞集落形成单位都是在体外产生的。然而,随着嗜中性粒细胞和巨噬细胞在培养物中积累,祖细胞的产生下降。此外,随着成熟髓样细胞的这种积累,培养物中可检测到超氧阴离子和过氧化氢水平升高,并且发现向培养基中添加抗氧化剂(过氧化氢酶和甘露醇)可增强可测量的祖细胞数量的每周扩增。这些发现支持这样的结论,即在人骨髓的长期“德克斯特”培养中,成熟髓样细胞产生的活性氧中间体在限制造血祖细胞自我更新的持续时间和程度方面起作用。